We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

By LabMedica International staff writers
Posted on 04 Apr 2025
Print article
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective management and treatment. For patients at low or moderate risk for PE, D-dimer testing is recommended as part of the diagnostic strategy, thanks to its high negative predictive value. However, in patients with a high clinical likelihood of PE, the high prevalence of the condition can reduce the negative predictive value of D-dimer testing, increasing the likelihood of diagnostic failure. As a result, guidelines suggest that high-risk patients undergo chest imaging (CI) directly, bypassing D-dimer testing. Yet, there is limited evidence to support this recommendation. A new study has sought to evaluate the safety of excluding PE based on D-dimer testing in patients with a high clinical probability of the condition.

Researchers at Pitié-Salpêtrière University Hospital (Paris, France), along with collaborators, conducted the study to address the uncertainty around ruling out PE in high-risk patients based on D-dimer levels. The study involved a post hoc analysis of three European studies (PROPER, MODIGLIANI, and TRYSPEED). Patients included in the analysis had a high clinical probability of PE, as determined by either the Wells or the revised Geneva score, and had undergone D-dimer testing.

The results, published in the peer-reviewed journal Academic Emergency Medicine, demonstrated that ruling out PE based on a D-dimer level below the age-adjusted threshold was safe, with no instances of missed pulmonary embolism. However, the sample size of the study was not large enough to definitively conclude the safety of this diagnostic approach. The findings could have significant implications for the clinical management of high-risk PE patients, but further research is required to confirm these results in larger populations.

Related Links:
Pitié-Salpêtrière University Hospital

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
Coagulation Analyzer
CS-2400

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.